Prevalence and Prognosis of Cardiac Amiloidosis in Turkey (PAPCAT)

Turkish Society of Cardiology

Status: Enrolling

Conditions: Cardiac Amyloidosis

Treatments: Behavioral: Algorithm

Study type: Observational

Funder types: Other

Identifiers

NCT04915235

PAPCAT

Details and patient eligibility

About

Patients with left ventricular hypertrophy are further examined according to an algorithm to check if they have a cardiac amyloidosis

Enrollment: 2,087 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with left ventricular hypertrophy without left ventricular pressure or volume (IVS≥13mm)
• Patients with left ventricular hypertrophy and hypertension or aortic stenosis without left ventricular pressure or volume (IVS>15mm)

Exclusion criteria

• Patients with left ventricular pressure or volume except the ones with aortic stenosis and arterial hypertension
• Patients with sigmoid septum and their hypertrophy limited in sigmoid area
• Patients with highly probable sarcometric hypertrophy cardiomyopathy confirmed with LV morhpology and genetic testing